FAM3B has been suggested to play important roles in the progression of many cancers, such as gastric, oral, colon and prostate cancer. However, little is known about the role of FAM3B in human esophageal squamous cell carcinoma (ESCC). In the present study, we found that FAM3B expression was higher in ESCC tissues than in adjacent normal tissues. Using quantitative real-time polymerase chain reaction, we found similar results in cell lines. FAM3B expression was significantly related to T/TNM stage. Importantly, Kaplan-Meier analysis revealed that a high expression level of FAM3B predicted a poor outcome for ESCC patients. Overexpression of FAM3B inhibits ESCC cell death, increases oesophageal tumour growth in xenografted nude mice, and promotes ESCC cell migration and invasion. Further studies confirmed that FAM3B regulates the AKT-MDM2-p53 pathway and two core epithelial-to-mesenchymal transition process markers, Snail and E-cadherin. Our results provide new insights into the role of FAM3B in the progression of ESCC and suggest that FAM3B may be a promising molecular target and diagnostic marker for ESCC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349344 | PMC |
| http://dx.doi.org/10.1111/jcmm.14040 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mendelian randomization analysis of plasma proteins reveals potential novel tumor markers for gastric cancer.
Sci Rep
January 2025
Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.
This study aimed to elucidate the potential causal relationship between 4,907 plasma proteins and the risk of gastric cancer using a two-sample Mendelian randomization approach. We utilized genome-wide association study (GWAS) data to perform two-sample Mendelian randomization analyses, treating the 4,907 plasma proteins as exposure factors and gastric cancer as the outcome. Instrumental variables for plasma proteins were selected based on strongly correlated SNPs identified through data processing and screening of the GWAS data provided by the deCode database.
View Article and Find Full Text PDFArticle Synopsis
- About one-third of breast cancer patients exhibit poorer cognitive function before starting therapy, and the study investigates the biological mechanisms behind this.
- Researchers used DNA methylation data from whole blood samples to perform epigenome-wide association studies (EWAS) and found specific genetic markers associated with cognitive functioning in postmenopausal women with hormone receptor-positive breast cancer.
- The study identified significant signals related to processing speed and subjective cognitive function, with estrogen playing a crucial role in these cognitive variations, suggesting the need for further research with larger sample sizes.
Antiapoptotic and Prometastatic Roles of Cytokine FAM3B in Triple-Negative Breast Cancer.
Clin Breast Cancer
October 2024
Multidisciplinary Research Center, School of Arts, Sciences and Humanities, University of São Paulo, CEP 03828000, Sao Paulo, Brazil. Electronic address:
Background: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. FAM3B, a secreted protein, has been extensively studied in various types of tumors. However, its function in breast cancer remains poorly understood.
View Article and Find Full Text PDFAn integrated machine learning framework for developing and validating a diagnostic model of major depressive disorder based on interstitial cystitis-related genes.
J Affect Disord
August 2024
Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061 Xi'an, Shaanxi, China. Electronic address:
Background: Major depressive disorder (MDD) and interstitial cystitis (IC) are two highly debilitating conditions that often coexist with reciprocal effect, significantly exacerbating patients' suffering. However, the molecular underpinnings linking these disorders remain poorly understood.
Methods: Transcriptomic data from GEO datasets including those of MDD and IC patients was systematically analyzed to develop and validate our model.
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.
J Natl Cancer Inst
March 2024
Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.
Article Synopsis
- - The study investigates the impact of TMPRSS2-ERG gene fusions in prostate cancer, highlighting that deletion-derived fusions are linked to more aggressive forms compared to insertional fusions.
- - Analysis of prostate cancer transcriptome data identified the loss of the FAM3B gene as a key factor correlated with poor prognosis, influencing not only TMPRSS2-ERG fusion cancers but also fusion-negative cases.
- - FAM3B's loss disrupts a regulatory feedback loop with the androgen receptor, leading to increased androgen receptor activity and accelerating prostate cancer progression, indicating its potential as a new target for treatment strategies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!